Eli Lilly & Co., US5324571083

Lam Research Corporation stock (US5324571083): Shares drop 2.3% to $289.24

13.05.2026 - 17:24:19 | ad-hoc-news.de

Lam Research Corporation (LRCX) stock declined 2.3% on May 12, 2026, closing at $289.24 amid sector weakness. Institutional moves noted as shares test 52-week highs.

Eli Lilly & Co., US5324571083
Eli Lilly & Co., US5324571083

Lam Research Corporation stock fell 2.30% on Tuesday, May 12, 2026, dropping from $296.05 to $289.24 on Nasdaq, StockInvest.us as of May 13, 2026. The decline aligned with broader semiconductor sector pressure, including drops in peers like MACOM and Marvell Technology. LRCX opened at $289.24 on Wednesday with a 52-week range of $79.49 to $300.00, MarketBeat as of May 13, 2026.

As of: 13.05.2026

By the editorial team – specialized in equity coverage.

At a glance

  • Name: Lam Research Corporation
  • Sector/industry: Semiconductors / Semiconductor equipment
  • Headquarters/country: Fremont, California, USA
  • Core markets: US, Asia-Pacific, Europe
  • Key revenue drivers: Wafer fabrication equipment, etch and deposition systems
  • Home exchange/listing venue: Nasdaq (LRCX)
  • Trading currency: USD

Official source

For first-hand information on Lam Research Corporation, visit the company’s official website.

Go to the official website

Lam Research Corporation: core business model

Lam Research Corporation designs, manufactures, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company focuses on etch, deposition, and clean technologies critical for advanced chip production. Its systems enable the creation of nanoscale features in logic, memory, and foundry semiconductors, serving major chipmakers worldwide. Lam Research generates revenue primarily from equipment sales, with recurring income from spares, services, and upgrades.

Headquartered in Fremont, California, the firm operates globally, with significant exposure to US-based foundries and logic producers. This positioning ties its performance closely to the US semiconductor industry's health, a key sector for American technology leadership and economic output.

Main revenue and product drivers for Lam Research Corporation

Etch systems represent a core revenue driver, accounting for a substantial portion of sales as demand grows for precise patterning in 3nm and below nodes. Deposition tools, including atomic layer deposition, support high-aspect-ratio structures in DRAM and NAND. The Flex and Kiyo product lines exemplify Lam's innovation in plasma etch for logic and memory chips. Services and parts contribute steady high-margin revenue, often exceeding 20% of total sales in recent periods.

Geographically, Asia-Pacific drives the majority of revenue due to fab expansions in Taiwan and South Korea, but US customers like Intel and GlobalFoundries provide critical exposure. Lam Research benefits from CHIPS Act incentives boosting domestic manufacturing, enhancing its relevance for US investors tracking reshoring trends.

Industry trends and competitive position

The semiconductor equipment sector faces cyclical demand tied to chip cycles, with AI and high-performance computing fueling growth. Lam Research holds a leading position in etch (around 50% market share) and strong deposition capabilities, competing with Applied Materials and Tokyo Electron. Analyst forecasts project 17-19% annual revenue growth through the decade, driven by node shrinks and 3D architectures, Simply Wall St as of May 2026.

Why Lam Research Corporation matters for US investors

As a Nasdaq-listed leader in wafer fab equipment, Lam Research offers US investors direct play on domestic semi recovery. Its tools power chips in smartphones, data centers, and EVs, with US fabs expanding under government support. The stock's volatility reflects sector swings but provides exposure to long-term trends like AI accelerators and advanced packaging.

Read more

Additional news and developments on the stock can be explored via the linked overview pages.

More news on this stockInvestor relations

Conclusion

Lam Research Corporation navigated recent sector headwinds with a 2.3% share drop on May 12, 2026, amid institutional activity. Its etch and deposition leadership positions it for AI-driven demand, though cyclical risks persist. US investors eye its role in domestic fab builds as a key differentiator in portfolios.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.

So schätzen die Börsenprofis Eli Lilly & Co. Aktien ein!

<b>So schätzen die Börsenprofis Eli Lilly &amp; Co. Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | US5324571083 | ELI LILLY & CO. | boerse | 69325807 | bgmi